Personalis, Inc. (PSNL)
NASDAQ: PSNL · Real-Time Price · USD
9.00
+0.43 (5.02%)
At close: Feb 18, 2026, 4:00 PM EST
8.94
-0.06 (-0.67%)
After-hours: Feb 18, 2026, 7:43 PM EST
Revenue by Segment
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 |
|---|
Advanced Cancer Genomic Tests for Precision Oncology and Personalized Testing | 84.61M | 73.48M | 65.05M | 85.49M | 78.65M | | | |
Advanced Cancer Genomic Tests for Precision Oncology and Personalized Testing Growth | 15.15% | 12.97% | -23.92% | 8.70% | 20.61% | | | |
| 84.61M | 73.48M | 65.05M | 85.49M | 78.65M | | | |
| 15.15% | 12.97% | -23.92% | 8.70% | 20.61% | | | |
Revenue by Geography
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 |
|---|
| 81.23M | 66.13M | 65.05M | 85.49M | 78.65M | | | |
| 22.83% | 1.67% | -23.92% | 8.70% | 20.61% | | | |
| 3.38M | 7.35M | - | - | - | | | |
| -53.94% | - | - | - | - | | | |
| 84.61M | 73.48M | 65.05M | 85.49M | 78.65M | | | |
| 15.15% | 12.97% | -23.92% | 8.70% | 20.61% | | | |
Source: S&P Global Market Intelligence.
